← Eichor
Study identifier: NCT05189808 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Radiofrequency Ablation for BIII Thyroid Nodules

Condition: Indeterminate Bethesda III Thyroid Nodules  ·  Sponsor: Columbia University

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The purpose of this observational chart review study is to evaluate the efficacy and safety of Radiofrequency Ablation (RFA) for treatment of indeterminate thyroid nodules before and after RFA procedure. This is a data collection study in which the investigators ask patients to give access to information generated before and after RFA treatment of their condition. The RFA procedure uses image guidance to place an electrode through the skin into the target area. In RFA, high-frequency electrical currents are passed through an electrode, creating a small region of heat to treat the lesion.

This description comes directly from the study's public registry record.

Talk to the study team

Jennifer H Kuo, MD MS  ·  212-305-6969  ·  jhk2029@cumc.columbia.edu

Catherine McManus, MD MS  ·  212-305-6969  ·  cm3304@cumc.columbia.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Columbia UniversityNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05189808